glp 1 l cells glp-1 secretion GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation Sympathetic nerve-enteroendocrine L cell communication

Authors: James Park, 3rd Year Student Pharmacist at UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences

Research suggests that individuals who regularly track their food intake often achieve better weight loss outcomes compared to those who do not, making this practice an important part of GLP-1 treatment

Using degraded medication may result in: Suboptimal blood glucose control in patients with type 2 diabetes Reduced weight loss efficacy for those using GLP-1 agonists for weight management Unpredictable dosing , as degradation may be partial rather than complete Patients with diabetes who suspect reduced medication efficacy should monitor their blood glucose more frequently and contact their GP or diabetes care team if they have concerns about medication storage or if their diabetes control deteriorates unexpectedly

Taking too much Evion LC Tablet may cause side effects like stomach upset, nausea, and diarrhea